Literature DB >> 10853711

Testosterone modulates serum leptin concentrations in a male patient with hypothalamic hypogonadism.

T Ogura1, K Tobe, Y Mimura, F Otsuka, T Yamauchi, A Imai, C Tsukamoto, Y Iwasaki, K Matsuura.   

Abstract

Serial measurements of body mass index (BMI), serum concentrations of testosterone (T), estradiol (E) and leptin (L) were performed before and after gonadotropin (Gn) therapy in an 18-year-old male subject (BMI 25.4 kg/m2) with idiopathic hypothalamic hypogonadism (IHH). We also measured the BMI and serum concentrations of L in 99 age-matched healthy subjects. Serum L correlated significantly with BMI in control subjects (r=0.84, p<0.0001). Baseline serum concentrations of L in our case were markedly high and both T and E were very low, but Gn therapy resulted in a gradual decrease in L and improvement in T and E, finally reaching the control levels of BMI-matched subjects. Our results demonstrate that T is a powerful negative modulator of serum L independent of BMI in conditions associated with low T levels, such as IHH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853711     DOI: 10.1007/BF03343716

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Contribution of androgens to the gender difference in leptin production in obese children and adolescents.

Authors:  M Wabitsch; W F Blum; R Muche; M Braun; F Hube; W Rascher; E Heinze; W Teller; H Hauner
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.

Authors:  F Jockenhövel; W F Blum; E Vogel; P Englaro; D Müller-Wieland; D Reinwein; W Rascher; W Krone
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

3.  Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.

Authors:  J M Elbers; H Asscheman; J C Seidell; M Frölich; A E Meinders; L J Gooren
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

4.  Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

Authors:  C T Montague; J B Prins; L Sanders; J E Digby; S O'Rahilly
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

5.  Leptin: a trigger for puberty?

Authors:  G Vogel
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

6.  Bioimpedance analysis: evaluation of leg-to-leg system based on pressure contact footpad electrodes.

Authors:  C Nuñez; D Gallagher; M Visser; F X Pi-Sunyer; Z Wang; S B Heymsfield
Journal:  Med Sci Sports Exerc       Date:  1997-04       Impact factor: 5.411

7.  A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty.

Authors:  C S Mantzoros; J S Flier; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

8.  Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.

Authors:  C Vaisse; J L Halaas; C M Horvath; J E Darnell; M Stoffel; J M Friedman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  2 in total

1.  Change in adipocytokines and ghrelin with menopause.

Authors:  MaryFran R Sowers; Rachel P Wildman; Peter Mancuso; Aimee D Eyvazzadeh; Carrie A Karvonen-Gutierrez; Eileen Rillamas-Sun; Mary L Jannausch
Journal:  Maturitas       Date:  2008-02-14       Impact factor: 4.342

2.  Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism.

Authors:  T Ogura; Y Mimura; F Otsuka; M Kishida; K Yokota; J Suzuki; A Nagai; S Hirakawa; H Makino; K Tobe
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.